These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35238428)

  • 1. The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic.
    Noble H; Hasan SS; Whorwell PJ; Vasant DH
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14347. PubMed ID: 35238428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
    Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
    Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
    Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More similarities than differences between men and women with irritable bowel syndrome.
    Björkman I; Jakobsson Ung E; Ringström G; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2015 Jun; 27(6):796-804. PubMed ID: 25817301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of latent links between irritable bowel syndrome and sleep quality.
    Bellini M; Gemignani A; Gambaccini D; Toti S; Menicucci D; Stasi C; Costa F; Mumolo MG; Ricchiuti A; Bedini R; de Bortoli N; Marchi S
    World J Gastroenterol; 2011 Dec; 17(46):5089-96. PubMed ID: 22171143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable bowel syndrome: a comparison of subtypes.
    Rey de Castro NG; Miller V; Carruthers HR; Whorwell PJ
    J Gastroenterol Hepatol; 2015 Feb; 30(2):279-85. PubMed ID: 25091059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age.
    Thakur ER; Quigley BM; El-Serag HB; Gudleski GD; Lackner JM
    J Psychosom Res; 2016 Sep; 88():48-53. PubMed ID: 27521653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Midenfjord I; Borg A; Törnblom H; Simrén M
    Am J Gastroenterol; 2021 Apr; 116(4):769-779. PubMed ID: 33982947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.
    Addante R; Naliboff B; Shih W; Presson AP; Tillisch K; Mayer EA; Chang L
    J Clin Gastroenterol; 2019 Apr; 53(4):e142-e149. PubMed ID: 29351154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease.
    Midenfjord I; Grinsvall C; Koj P; Carnerup I; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14156. PubMed ID: 33860970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid extra-intestinal central sensitization conditions worsen irritable bowel syndrome in primary care patients.
    Wang XJ; Ebbert JO; Loftus CG; Rosedahl JK; Philpot LM
    Neurogastroenterol Motil; 2023 Apr; 35(4):e14546. PubMed ID: 36807964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct associations of DSM-5 Somatic Symptom Disorder, the Diagnostic Criteria for Psychosomatic Research-Revised (DCPR-R) and symptom severity in patients with irritable bowel syndrome.
    Porcelli P; De Carne M; Leandro G
    Gen Hosp Psychiatry; 2020; 64():56-62. PubMed ID: 32199282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of the COVID pandemic on the anxiety of patients with functional gastrointestinal symptoms].
    Goebel-Stengel M; Lohmiller J; Schäffeler N; Zipfel S; Stengel A
    Z Gastroenterol; 2022 Apr; 60(4):575-585. PubMed ID: 35176808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety-related factors associated with symptom severity in irritable bowel syndrome.
    Black CJ; Yiannakou Y; Houghton LA; Shuweihdi F; West R; Guthrie E; Ford AC
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13872. PubMed ID: 32396247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness.
    Knowles SR; Austin DW; Sivanesan S; Tye-Din J; Leung C; Wilson J; Castle D; Kamm MA; Macrae F; Hebbard G
    Psychol Health Med; 2017 Jun; 22(5):524-534. PubMed ID: 27045996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.
    Midenfjord I; Polster A; Sjövall H; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2019 Aug; 31(8):e13619. PubMed ID: 31056802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.